Market Research Logo

Generics in South Korea

Generics in South Korea

Summary

Generics in South Korea industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis

Essential resource for top-line data and analysis covering the South Korea generics market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Key Highlights

  • For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included.
  • The South Korean generics market had total revenues of $4.8bn in 2017, representing a compound annual growth rate (CAGR) of 8.3% between 2013 and 2017.
  • Market consumption volume increased with a CAGR of 3.3% between 2013 and 2017, to reach a total of 71% in 2017.
  • Generics are becoming more and more popular in South Korea as the government realizes the cost saving potential.
Scope
  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the generics market in South Korea
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in South Korea
  • Leading company profiles reveal details of key generics market players’ global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the South Korea generics market with five year forecasts by both value and volume
Reasons to buy
  • What was the size of the South Korea generics market by value in 2017?
  • What will be the size of the South Korea generics market in 2022?
  • What factors are affecting the strength of competition in the South Korea generics market?
  • How has the market performed over the last five years?
  • How large is South Korea’s generics market in relation to its regional counterparts?


Executive Summary
Market value
Market value forecast
Market volume
Market volume forecast
Geography segmentation
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market volume
Market Segmentation
Geography segmentation
Market Outlook
Market value forecast
Market volume forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
Mylan N.V.
Novartis AG
Teva Pharmaceutical Industries Limited
Yuhan Corp
Macroeconomic Indicators
Country data
Methodology
Industry associations
Related MarketLine research
Appendix
About MarketLine
List of Tables
Table 1: South Korea generics market value: $ million, 2013-17
Table 2: South Korea generics market volume: % of total pharma, 2013-17
Table 3: South Korea generics market geography segmentation: $ million, 2017
Table 4: South Korea generics market value forecast: $ million, 2017-22
Table 5: South Korea generics market volume forecast: % of total pharma, 2017-22
Table 6: Mylan N.V.: key facts
Table 7: Mylan N.V.: key financials ($)
Table 8: Mylan N.V.: key financial ratios
Table 9: Novartis AG: key facts
Table 10: Novartis AG: key financials ($)
Table 11: Novartis AG: key financial ratios
Table 12: Teva Pharmaceutical Industries Limited: key facts
Table 13: Teva Pharmaceutical Industries Limited: key financials ($)
Table 14: Teva Pharmaceutical Industries Limited: key financial ratios
Table 15: Yuhan Corp: key facts
Table 16: Yuhan Corp: key financials ($)
Table 17: Yuhan Corp: key financials (KRW)
Table 18: Yuhan Corp: key financial ratios
Table 19: South Korea size of population (million), 2013-17
Table 20: South Korea gdp (constant 2005 prices, $ billion), 2013-17
Table 21: South Korea gdp (current prices, $ billion), 2013-17
Table 22: South Korea inflation, 2013-17
Table 23: South Korea consumer price index (absolute), 2013-17
Table 24: South Korea exchange rate, 2013-17
List of Figures
Figure 1: South Korea generics market value: $ million, 2013-17
Figure 2: South Korea generics market volume: % of total pharma, 2013-17
Figure 3: South Korea generics market geography segmentation: % share, by value, 2017
Figure 4: South Korea generics market value forecast: $ million, 2017-22
Figure 5: South Korea generics market volume forecast: % of total pharma, 2017-22
Figure 6: Forces driving competition in the generics market in South Korea, 2017
Figure 7: Drivers of buyer power in the generics market in South Korea, 2017
Figure 8: Drivers of supplier power in the generics market in South Korea, 2017
Figure 9: Factors influencing the likelihood of new entrants in the generics market in South Korea, 2017
Figure 10: Factors influencing the threat of substitutes in the generics market in South Korea, 2017
Figure 11: Drivers of degree of rivalry in the generics market in South Korea, 2017
Figure 12: Mylan N.V.: revenues & profitability
Figure 13: Mylan N.V.: assets & liabilities
Figure 14: Novartis AG: revenues & profitability
Figure 15: Novartis AG: assets & liabilities
Figure 16: Teva Pharmaceutical Industries Limited: revenues & profitability
Figure 17: Teva Pharmaceutical Industries Limited: assets & liabilities
Figure 18: Yuhan Corp: revenues & profitability
Figure 19: Yuhan Corp: assets & liabilities

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report